In order to explore whether quercetin, naringenin, and naringin were capable of influencing aromatase levels in solid tumors, an in vivo animal model of EAC solid tumor was used and aromatase levels were determined in tumor homogenates of control and treated groups. Here, CYP19A1 is linked to neoplasm.